nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—ankylosing spondylitis	0.253	0.351	CbGbCtD
Zaleplon—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0954	0.132	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0635	0.088	CbGbCtD
Zaleplon—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0635	0.088	CbGbCtD
Zaleplon—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0491	0.0681	CbGbCtD
Zaleplon—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0476	0.066	CbGbCtD
Zaleplon—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0372	0.0516	CbGbCtD
Zaleplon—CYP3A4—Betamethasone—ankylosing spondylitis	0.0319	0.0443	CbGbCtD
Zaleplon—CYP3A4—Prednisolone—ankylosing spondylitis	0.0315	0.0437	CbGbCtD
Zaleplon—CYP3A4—Prednisone—ankylosing spondylitis	0.0297	0.0413	CbGbCtD
Zaleplon—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0186	0.0258	CbGbCtD
Zaleplon—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000377	0.00135	CcSEcCtD
Zaleplon—Syncope—Methylprednisolone—ankylosing spondylitis	0.000376	0.00135	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000373	0.00134	CcSEcCtD
Zaleplon—Oedema—Prednisolone—ankylosing spondylitis	0.000373	0.00134	CcSEcCtD
Zaleplon—Dysuria—Methotrexate—ankylosing spondylitis	0.000373	0.00134	CcSEcCtD
Zaleplon—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000369	0.00132	CcSEcCtD
Zaleplon—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000369	0.00132	CcSEcCtD
Zaleplon—Shock—Prednisolone—ankylosing spondylitis	0.000367	0.00132	CcSEcCtD
Zaleplon—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000367	0.00132	CcSEcCtD
Zaleplon—Tachycardia—Prednisolone—ankylosing spondylitis	0.000364	0.0013	CcSEcCtD
Zaleplon—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000364	0.0013	CcSEcCtD
Zaleplon—Hypertension—Triamcinolone—ankylosing spondylitis	0.000363	0.0013	CcSEcCtD
Zaleplon—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000362	0.0013	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000361	0.00129	CcSEcCtD
Zaleplon—Myalgia—Triamcinolone—ankylosing spondylitis	0.000358	0.00128	CcSEcCtD
Zaleplon—Pneumonia—Methotrexate—ankylosing spondylitis	0.000357	0.00128	CcSEcCtD
Zaleplon—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000357	0.00128	CcSEcCtD
Zaleplon—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000357	0.00128	CcSEcCtD
Zaleplon—Eye disorder—Prednisone—ankylosing spondylitis	0.000357	0.00128	CcSEcCtD
Zaleplon—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000356	0.00128	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000355	0.00127	CcSEcCtD
Zaleplon—Depression—Methotrexate—ankylosing spondylitis	0.000354	0.00127	CcSEcCtD
Zaleplon—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000354	0.00127	CcSEcCtD
Zaleplon—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000354	0.00127	CcSEcCtD
Zaleplon—Discomfort—Triamcinolone—ankylosing spondylitis	0.000354	0.00127	CcSEcCtD
Zaleplon—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000353	0.00126	CcSEcCtD
Zaleplon—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00035	0.00125	CcSEcCtD
Zaleplon—Angioedema—Betamethasone—ankylosing spondylitis	0.000349	0.00125	CcSEcCtD
Zaleplon—Angioedema—Dexamethasone—ankylosing spondylitis	0.000349	0.00125	CcSEcCtD
Zaleplon—Stomatitis—Methotrexate—ankylosing spondylitis	0.000346	0.00124	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000345	0.00124	CcSEcCtD
Zaleplon—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000345	0.00124	CcSEcCtD
Zaleplon—Immune system disorder—Prednisone—ankylosing spondylitis	0.000345	0.00124	CcSEcCtD
Zaleplon—Malaise—Betamethasone—ankylosing spondylitis	0.000344	0.00123	CcSEcCtD
Zaleplon—Malaise—Dexamethasone—ankylosing spondylitis	0.000344	0.00123	CcSEcCtD
Zaleplon—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000343	0.00123	CcSEcCtD
Zaleplon—Oedema—Triamcinolone—ankylosing spondylitis	0.000343	0.00123	CcSEcCtD
Zaleplon—Vertigo—Betamethasone—ankylosing spondylitis	0.000343	0.00123	CcSEcCtD
Zaleplon—Vertigo—Dexamethasone—ankylosing spondylitis	0.000343	0.00123	CcSEcCtD
Zaleplon—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000342	0.00123	CcSEcCtD
Zaleplon—Syncope—Betamethasone—ankylosing spondylitis	0.000342	0.00123	CcSEcCtD
Zaleplon—Syncope—Dexamethasone—ankylosing spondylitis	0.000342	0.00123	CcSEcCtD
Zaleplon—Sweating—Methotrexate—ankylosing spondylitis	0.000341	0.00122	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—ankylosing spondylitis	0.000339	0.00121	CcSEcCtD
Zaleplon—Shock—Triamcinolone—ankylosing spondylitis	0.000338	0.00121	CcSEcCtD
Zaleplon—Insomnia—Prednisolone—ankylosing spondylitis	0.000337	0.00121	CcSEcCtD
Zaleplon—Alopecia—Prednisone—ankylosing spondylitis	0.000337	0.00121	CcSEcCtD
Zaleplon—Shock—Methylprednisolone—ankylosing spondylitis	0.000337	0.00121	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000336	0.0012	CcSEcCtD
Zaleplon—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000336	0.0012	CcSEcCtD
Zaleplon—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000335	0.0012	CcSEcCtD
Zaleplon—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000335	0.0012	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—ankylosing spondylitis	0.000335	0.0012	CcSEcCtD
Zaleplon—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000335	0.0012	CcSEcCtD
Zaleplon—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000335	0.0012	CcSEcCtD
Zaleplon—Mental disorder—Prednisone—ankylosing spondylitis	0.000334	0.0012	CcSEcCtD
Zaleplon—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000334	0.0012	CcSEcCtD
Zaleplon—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000333	0.00119	CcSEcCtD
Zaleplon—Malnutrition—Prednisone—ankylosing spondylitis	0.000332	0.00119	CcSEcCtD
Zaleplon—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000332	0.00119	CcSEcCtD
Zaleplon—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000331	0.00119	CcSEcCtD
Zaleplon—Hypertension—Dexamethasone—ankylosing spondylitis	0.000329	0.00118	CcSEcCtD
Zaleplon—Hypertension—Betamethasone—ankylosing spondylitis	0.000329	0.00118	CcSEcCtD
Zaleplon—Myalgia—Dexamethasone—ankylosing spondylitis	0.000325	0.00116	CcSEcCtD
Zaleplon—Myalgia—Betamethasone—ankylosing spondylitis	0.000325	0.00116	CcSEcCtD
Zaleplon—Anxiety—Dexamethasone—ankylosing spondylitis	0.000324	0.00116	CcSEcCtD
Zaleplon—Anxiety—Betamethasone—ankylosing spondylitis	0.000324	0.00116	CcSEcCtD
Zaleplon—Discomfort—Betamethasone—ankylosing spondylitis	0.000321	0.00115	CcSEcCtD
Zaleplon—Discomfort—Dexamethasone—ankylosing spondylitis	0.000321	0.00115	CcSEcCtD
Zaleplon—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00032	0.00115	CcSEcCtD
Zaleplon—Pain—Prednisolone—ankylosing spondylitis	0.000319	0.00114	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000313	0.00112	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000312	0.00112	CcSEcCtD
Zaleplon—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000311	0.00112	CcSEcCtD
Zaleplon—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000311	0.00112	CcSEcCtD
Zaleplon—Oedema—Betamethasone—ankylosing spondylitis	0.000311	0.00112	CcSEcCtD
Zaleplon—Oedema—Dexamethasone—ankylosing spondylitis	0.000311	0.00112	CcSEcCtD
Zaleplon—Insomnia—Triamcinolone—ankylosing spondylitis	0.00031	0.00111	CcSEcCtD
Zaleplon—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00031	0.00111	CcSEcCtD
Zaleplon—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000308	0.0011	CcSEcCtD
Zaleplon—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000308	0.0011	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000307	0.0011	CcSEcCtD
Zaleplon—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000307	0.0011	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—ankylosing spondylitis	0.000307	0.0011	CcSEcCtD
Zaleplon—Anaemia—Prednisone—ankylosing spondylitis	0.000307	0.0011	CcSEcCtD
Zaleplon—Shock—Betamethasone—ankylosing spondylitis	0.000306	0.0011	CcSEcCtD
Zaleplon—Shock—Dexamethasone—ankylosing spondylitis	0.000306	0.0011	CcSEcCtD
Zaleplon—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000306	0.0011	CcSEcCtD
Zaleplon—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000305	0.00109	CcSEcCtD
Zaleplon—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000305	0.00109	CcSEcCtD
Zaleplon—Agitation—Prednisone—ankylosing spondylitis	0.000305	0.00109	CcSEcCtD
Zaleplon—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000304	0.00109	CcSEcCtD
Zaleplon—Tachycardia—Betamethasone—ankylosing spondylitis	0.000304	0.00109	CcSEcCtD
Zaleplon—Angioedema—Prednisone—ankylosing spondylitis	0.000304	0.00109	CcSEcCtD
Zaleplon—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000302	0.00108	CcSEcCtD
Zaleplon—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000301	0.00108	CcSEcCtD
Zaleplon—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000301	0.00108	CcSEcCtD
Zaleplon—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000301	0.00108	CcSEcCtD
Zaleplon—Malaise—Prednisone—ankylosing spondylitis	0.0003	0.00107	CcSEcCtD
Zaleplon—Vertigo—Prednisone—ankylosing spondylitis	0.000298	0.00107	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—ankylosing spondylitis	0.000298	0.00107	CcSEcCtD
Zaleplon—Syncope—Prednisone—ankylosing spondylitis	0.000298	0.00107	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—ankylosing spondylitis	0.000297	0.00107	CcSEcCtD
Zaleplon—Anorexia—Betamethasone—ankylosing spondylitis	0.000297	0.00106	CcSEcCtD
Zaleplon—Anorexia—Dexamethasone—ankylosing spondylitis	0.000297	0.00106	CcSEcCtD
Zaleplon—Urticaria—Prednisolone—ankylosing spondylitis	0.000296	0.00106	CcSEcCtD
Zaleplon—Pain—Triamcinolone—ankylosing spondylitis	0.000293	0.00105	CcSEcCtD
Zaleplon—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000292	0.00105	CcSEcCtD
Zaleplon—Hypotension—Dexamethasone—ankylosing spondylitis	0.000291	0.00104	CcSEcCtD
Zaleplon—Hypotension—Betamethasone—ankylosing spondylitis	0.000291	0.00104	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000288	0.00103	CcSEcCtD
Zaleplon—Hypertension—Prednisone—ankylosing spondylitis	0.000287	0.00103	CcSEcCtD
Zaleplon—Chills—Methotrexate—ankylosing spondylitis	0.000286	0.00103	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000284	0.00102	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000284	0.00102	CcSEcCtD
Zaleplon—Myalgia—Prednisone—ankylosing spondylitis	0.000283	0.00101	CcSEcCtD
Zaleplon—Arthralgia—Prednisone—ankylosing spondylitis	0.000283	0.00101	CcSEcCtD
Zaleplon—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000283	0.00101	CcSEcCtD
Zaleplon—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000282	0.00101	CcSEcCtD
Zaleplon—Anxiety—Prednisone—ankylosing spondylitis	0.000282	0.00101	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—ankylosing spondylitis	0.000282	0.00101	CcSEcCtD
Zaleplon—Insomnia—Dexamethasone—ankylosing spondylitis	0.000282	0.00101	CcSEcCtD
Zaleplon—Insomnia—Betamethasone—ankylosing spondylitis	0.000282	0.00101	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000281	0.00101	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00028	0.001	CcSEcCtD
Zaleplon—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00028	0.001	CcSEcCtD
Zaleplon—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00028	0.001	CcSEcCtD
Zaleplon—Discomfort—Prednisone—ankylosing spondylitis	0.000279	0.001	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—ankylosing spondylitis	0.000279	0.001	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—ankylosing spondylitis	0.000278	0.000995	CcSEcCtD
Zaleplon—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000274	0.000982	CcSEcCtD
Zaleplon—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000274	0.000982	CcSEcCtD
Zaleplon—Urticaria—Triamcinolone—ankylosing spondylitis	0.000273	0.000977	CcSEcCtD
Zaleplon—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000272	0.000975	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000272	0.000974	CcSEcCtD
Zaleplon—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000271	0.000972	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000271	0.000972	CcSEcCtD
Zaleplon—Oedema—Prednisone—ankylosing spondylitis	0.000271	0.000972	CcSEcCtD
Zaleplon—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000271	0.00097	CcSEcCtD
Zaleplon—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000271	0.00097	CcSEcCtD
Zaleplon—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000271	0.00097	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000269	0.000963	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000269	0.000963	CcSEcCtD
Zaleplon—Back pain—Methotrexate—ankylosing spondylitis	0.000269	0.000962	CcSEcCtD
Zaleplon—Shock—Prednisone—ankylosing spondylitis	0.000267	0.000956	CcSEcCtD
Zaleplon—Pain—Betamethasone—ankylosing spondylitis	0.000266	0.000954	CcSEcCtD
Zaleplon—Pain—Dexamethasone—ankylosing spondylitis	0.000266	0.000954	CcSEcCtD
Zaleplon—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000266	0.000953	CcSEcCtD
Zaleplon—Tachycardia—Prednisone—ankylosing spondylitis	0.000265	0.000948	CcSEcCtD
Zaleplon—Skin disorder—Prednisone—ankylosing spondylitis	0.000263	0.000944	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000262	0.000939	CcSEcCtD
Zaleplon—Anorexia—Prednisone—ankylosing spondylitis	0.000258	0.000926	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000258	0.000923	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—ankylosing spondylitis	0.000257	0.00092	CcSEcCtD
Zaleplon—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000257	0.000919	CcSEcCtD
Zaleplon—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000257	0.000919	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000255	0.000912	CcSEcCtD
Zaleplon—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000255	0.000912	CcSEcCtD
Zaleplon—Malaise—Methotrexate—ankylosing spondylitis	0.00025	0.000897	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—ankylosing spondylitis	0.000249	0.000894	CcSEcCtD
Zaleplon—Urticaria—Betamethasone—ankylosing spondylitis	0.000247	0.000886	CcSEcCtD
Zaleplon—Urticaria—Dexamethasone—ankylosing spondylitis	0.000247	0.000886	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000247	0.000885	CcSEcCtD
Zaleplon—Dizziness—Prednisolone—ankylosing spondylitis	0.000247	0.000884	CcSEcCtD
Zaleplon—Asthenia—Triamcinolone—ankylosing spondylitis	0.000246	0.000882	CcSEcCtD
Zaleplon—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000246	0.000882	CcSEcCtD
Zaleplon—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000246	0.000882	CcSEcCtD
Zaleplon—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000246	0.000882	CcSEcCtD
Zaleplon—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000246	0.000882	CcSEcCtD
Zaleplon—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000246	0.00088	CcSEcCtD
Zaleplon—Insomnia—Prednisone—ankylosing spondylitis	0.000245	0.000879	CcSEcCtD
Zaleplon—Paraesthesia—Prednisone—ankylosing spondylitis	0.000243	0.000872	CcSEcCtD
Zaleplon—Pruritus—Triamcinolone—ankylosing spondylitis	0.000243	0.00087	CcSEcCtD
Zaleplon—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000242	0.000868	CcSEcCtD
Zaleplon—Dyspepsia—Prednisone—ankylosing spondylitis	0.000239	0.000855	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—ankylosing spondylitis	0.000236	0.000847	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—ankylosing spondylitis	0.000236	0.000847	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—ankylosing spondylitis	0.000236	0.000847	CcSEcCtD
Zaleplon—Decreased appetite—Prednisone—ankylosing spondylitis	0.000236	0.000845	CcSEcCtD
Zaleplon—Rash—Prednisolone—ankylosing spondylitis	0.000235	0.000843	CcSEcCtD
Zaleplon—Dermatitis—Prednisolone—ankylosing spondylitis	0.000235	0.000842	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000235	0.000841	CcSEcCtD
Zaleplon—Headache—Prednisolone—ankylosing spondylitis	0.000234	0.000838	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—ankylosing spondylitis	0.000234	0.000837	CcSEcCtD
Zaleplon—Constipation—Prednisone—ankylosing spondylitis	0.000232	0.000831	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—ankylosing spondylitis	0.000228	0.000819	CcSEcCtD
Zaleplon—Dizziness—Triamcinolone—ankylosing spondylitis	0.000227	0.000813	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000227	0.000812	CcSEcCtD
Zaleplon—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000226	0.000811	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000223	0.000801	CcSEcCtD
Zaleplon—Asthenia—Dexamethasone—ankylosing spondylitis	0.000223	0.0008	CcSEcCtD
Zaleplon—Asthenia—Betamethasone—ankylosing spondylitis	0.000223	0.0008	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000222	0.000796	CcSEcCtD
Zaleplon—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000222	0.000794	CcSEcCtD
Zaleplon—Nausea—Prednisolone—ankylosing spondylitis	0.000222	0.000794	CcSEcCtD
Zaleplon—Pruritus—Dexamethasone—ankylosing spondylitis	0.00022	0.000789	CcSEcCtD
Zaleplon—Pruritus—Betamethasone—ankylosing spondylitis	0.00022	0.000789	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—ankylosing spondylitis	0.00022	0.000789	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000219	0.000785	CcSEcCtD
Zaleplon—Rash—Triamcinolone—ankylosing spondylitis	0.000216	0.000775	CcSEcCtD
Zaleplon—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000216	0.000775	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—ankylosing spondylitis	0.000216	0.000774	CcSEcCtD
Zaleplon—Rash—Methylprednisolone—ankylosing spondylitis	0.000216	0.000774	CcSEcCtD
Zaleplon—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000216	0.000773	CcSEcCtD
Zaleplon—Urticaria—Prednisone—ankylosing spondylitis	0.000215	0.000772	CcSEcCtD
Zaleplon—Headache—Triamcinolone—ankylosing spondylitis	0.000215	0.00077	CcSEcCtD
Zaleplon—Headache—Methylprednisolone—ankylosing spondylitis	0.000214	0.000769	CcSEcCtD
Zaleplon—Abdominal pain—Prednisone—ankylosing spondylitis	0.000214	0.000768	CcSEcCtD
Zaleplon—Body temperature increased—Prednisone—ankylosing spondylitis	0.000214	0.000768	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—ankylosing spondylitis	0.000212	0.000759	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000206	0.00074	CcSEcCtD
Zaleplon—Dizziness—Betamethasone—ankylosing spondylitis	0.000206	0.000738	CcSEcCtD
Zaleplon—Dizziness—Dexamethasone—ankylosing spondylitis	0.000206	0.000738	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—ankylosing spondylitis	0.000205	0.000734	CcSEcCtD
Zaleplon—Nausea—Triamcinolone—ankylosing spondylitis	0.000204	0.00073	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000203	0.000729	CcSEcCtD
Zaleplon—Nausea—Methylprednisolone—ankylosing spondylitis	0.000203	0.000729	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000202	0.000724	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—ankylosing spondylitis	0.000201	0.000722	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000199	0.000715	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000197	0.000706	CcSEcCtD
Zaleplon—Rash—Betamethasone—ankylosing spondylitis	0.000196	0.000703	CcSEcCtD
Zaleplon—Rash—Dexamethasone—ankylosing spondylitis	0.000196	0.000703	CcSEcCtD
Zaleplon—Dermatitis—Betamethasone—ankylosing spondylitis	0.000196	0.000703	CcSEcCtD
Zaleplon—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000196	0.000703	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000196	0.000701	CcSEcCtD
Zaleplon—Headache—Dexamethasone—ankylosing spondylitis	0.000195	0.000699	CcSEcCtD
Zaleplon—Headache—Betamethasone—ankylosing spondylitis	0.000195	0.000699	CcSEcCtD
Zaleplon—Asthenia—Prednisone—ankylosing spondylitis	0.000195	0.000697	CcSEcCtD
Zaleplon—Pain—Methotrexate—ankylosing spondylitis	0.000194	0.000694	CcSEcCtD
Zaleplon—Pruritus—Prednisone—ankylosing spondylitis	0.000192	0.000687	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000187	0.000669	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000185	0.000664	CcSEcCtD
Zaleplon—Nausea—Betamethasone—ankylosing spondylitis	0.000185	0.000663	CcSEcCtD
Zaleplon—Nausea—Dexamethasone—ankylosing spondylitis	0.000185	0.000663	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—ankylosing spondylitis	0.00018	0.000645	CcSEcCtD
Zaleplon—Dizziness—Prednisone—ankylosing spondylitis	0.000179	0.000642	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000179	0.000642	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000179	0.000642	CcSEcCtD
Zaleplon—Rash—Prednisone—ankylosing spondylitis	0.000171	0.000613	CcSEcCtD
Zaleplon—Dermatitis—Prednisone—ankylosing spondylitis	0.000171	0.000612	CcSEcCtD
Zaleplon—Headache—Prednisone—ankylosing spondylitis	0.00017	0.000609	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—ankylosing spondylitis	0.000163	0.000583	CcSEcCtD
Zaleplon—Nausea—Prednisone—ankylosing spondylitis	0.000161	0.000577	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—ankylosing spondylitis	0.00016	0.000574	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—ankylosing spondylitis	0.00015	0.000537	CcSEcCtD
Zaleplon—Rash—Methotrexate—ankylosing spondylitis	0.000143	0.000512	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—ankylosing spondylitis	0.000143	0.000511	CcSEcCtD
Zaleplon—Headache—Methotrexate—ankylosing spondylitis	0.000142	0.000509	CcSEcCtD
Zaleplon—Nausea—Methotrexate—ankylosing spondylitis	0.000135	0.000482	CcSEcCtD
